As for the kidney, it has been show that OPG is increased in patients with non-diabetic [22, 23] and diabetic chronic kidney disease (CKD) [24–26], where it predicts deterioration of kidney function, vascular events, cardiovascular and all-cause mortality [25]. This evidence concerns the gene TNFRSF11B and chronic kidney disease.